Balduini W, Cimino M, Depoortere H, Cattabeni F
Istituto di Farmacologia e Farmacognosia, Università di Urbino, Italy.
Eur J Pharmacol. 1999 Jul 2;376(1-2):149-57. doi: 10.1016/s0014-2999(99)00371-4.
Thiocolchicoside, a semi-synthetic derivative of the naturally occurring compound colchicoside with a relaxant effect on skeletal muscle, has been found to displace both [3H]gamma-aminobutyric acid ([3H]GABA) and [3H]strychnine binding, suggesting an interaction with both GABA and strychnine-sensitive glycine receptors. In order to gain further insight into the interaction of thiocolchicoside with these receptors, the binding of [3H]thiocolchicoside in rat spinal cord-brainstem and cortical synaptic membranes was characterized. [3H]Thiocolchicoside binding was saturable in both tissues examined. In spinal cord-brainstem membranes, we found a K(D) of 254 +/- 47 nM and a Bmax of 2.39 +/- 0.36 pmol/mg protein, whereas in cortical membranes, a K(D) of 176 nM and a Bmax of 4.20 pmol/mg protein was observed. A similar K(D) value was found in kinetic experiments performed in spinal cord-brainstem membranes. Heterologous displacement experiments showed that GABA and strychnine displaced the binding in a dose-dependent manner, whereas glycine was ineffective. [3H]Thiocolchicoside binding was also displaced by several GABA(A) receptor agonists and antagonists, but not by baclofen, flunitrazepam, guvacine, picrotoxin or by other drugs unrelated to GABA transmission. In spinal cord-brainstem, and to a lower extent, in cortical membranes, GABA and its analogs were not able to completely displace [3H]thiocolchicoside specific binding indicating that, besides GABA(A) receptors, thiocolchicoside can bind to another unidentified site. Unlabelled thiocolchicoside, however, completely displaced [3H]muscimol binding both in cortical and in spinal cord-brainstem synaptic membranes with an IC50 in the low microM range. Neurosteroids were found to modulate the binding in cortical but not in spinal cord-brainstem synaptic membranes. We conclude that [3H]thiocolchicoside binding shows a pharmacological profile indicating an interaction with the GABA(A) receptor. The different affinities for the GABA(A) receptor agonists and antagonists and sensitivity to neurosteroids obtained in the cerebral cortex and in the spinal cord may indicate a preferential interaction of the compound with a subtype of the GABA(A) receptor. The data also indicate that [3H]thiocolchicoside binds to another site(s), whose nature remains to be elucidated.
硫代秋水仙苷是天然存在的化合物秋水仙苷的半合成衍生物,对骨骼肌有松弛作用,已发现它能取代[³H]γ-氨基丁酸([³H]GABA)和[³H]士的宁的结合,提示其与GABA和士的宁敏感的甘氨酸受体都有相互作用。为了进一步深入了解硫代秋水仙苷与这些受体的相互作用,对大鼠脊髓-脑干和皮质突触膜中[³H]硫代秋水仙苷的结合进行了表征。在所检测的两种组织中,[³H]硫代秋水仙苷的结合都是可饱和的。在脊髓-脑干膜中,我们发现解离常数(K(D))为254±47 nM,最大结合量(Bmax)为2.39±0.36 pmol/mg蛋白,而在皮质膜中,观察到K(D)为176 nM,Bmax为4.20 pmol/mg蛋白。在脊髓-脑干膜中进行的动力学实验中发现了类似的K(D)值。异源置换实验表明,GABA和士的宁以剂量依赖性方式置换结合,而甘氨酸无效。[³H]硫代秋水仙苷的结合也被几种GABA(A)受体激动剂和拮抗剂置换,但不被巴氯芬、氟硝西泮、胍氨酸、印防己毒素或其他与GABA传递无关的药物置换。在脊髓-脑干以及程度较低的皮质膜中,GABA及其类似物不能完全置换[³H]硫代秋水仙苷的特异性结合,这表明除了GABA(A)受体外,硫代秋水仙苷还能与另一个未鉴定的位点结合。然而,未标记的硫代秋水仙苷在皮质和脊髓-脑干突触膜中都能完全置换[³H]蝇蕈醇的结合,其半数抑制浓度(IC50)在低微摩尔范围内。发现神经甾体可调节皮质突触膜中的结合,但不能调节脊髓-脑干突触膜中的结合。我们得出结论,[³H]硫代秋水仙苷的结合显示出一种药理学特征,表明其与GABA(A)受体有相互作用。在大脑皮质和脊髓中获得的对GABA(A)受体激动剂和拮抗剂的不同亲和力以及对神经甾体的敏感性,可能表明该化合物与GABA(A)受体的一种亚型有优先相互作用。数据还表明,[³H]硫代秋水仙苷与另一个位点结合,其性质有待阐明。